Free Trial

Dahlman Rose's Rating of Frontline on 3/28/2012

On March 28, 2012, Dahlman Rose updated its outlook on Frontline (NYSE:FRO) with the action "Upgrade", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.